Immatics’ PRAME-Directed TCR T-Cell Therapy Drives Deep Remission in Pediatric Solid Tumor Case

Individual experimental treatment attempt at Hopp Children’s Cancer Center Heidelberg (KiTZ) and Heidelberg University Hospital (UKHD) using a TC...

April 21, 2026 | Tuesday | News
Sanofi’s Nuvaxovid Shows Superior Tolerability vs mNEXSPIKE in Head-to-Head Study

Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study First head-to-head, double-blind, randomized phase...

April 21, 2026 | Tuesday | Reports
KIMMTRAK Doubles Five-Year Survival in First-Line Metastatic Uveal Melanoma

KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma OS benefit observed ac...

April 21, 2026 | Tuesday | News
PRAME-Targeted TCR T-Cell Therapy Drives Deep Remission in Pediatric Cancer Case

Individual experimental treatment attempt at Hopp Children’s Cancer Center Heidelberg (KiTZ) and Heidelberg University Hospital (UKHD) using a TC...

April 20, 2026 | Monday | News
Evaxion’s EVX-01 Shows Record 86% Immune Response Rate in Phase 2 Personalized Cancer Vaccine Study

New phase 2 data from personalized cancer vaccine EVX-01 demonstrates a record-high rate of vaccine targets triggering a tumor-specific immune response...

April 20, 2026 | Monday | News
Cepheid And Oxford Nanopore Expand Collaboration To Advance Rapid Pathogen Genomic Workflows

Phase two collaboration aims to expand access to streamlined genomic workflows for infectious disease research Cepheid, a Danaher company and a leader i...

April 16, 2026 | Thursday | News
Eli Lilly and Company Showcases Dual-Therapy Breakthrough in Psoriatic Arthritis and Obesity at AAD 2026

Eli Lilly and Company announced detailed results from the TOGETHER-PsA open-label Phase 3b clinical trial evaluating the concomitant use of Taltz (ixekiz...

March 30, 2026 | Monday | News
ATA-200 Gene Therapy Shows Early Clinical Promise for LGMD-R5 in First Patients

Atamyo Therapeutics, a biotechnology company specializing in the development of next-generation gene therapies for limb-girdle muscular dystrophy (LGMD),...

March 10, 2026 | Tuesday | News
Celltrion, Inc. Highlights Subcutaneous Infliximab’s Ability to Restore and Sustain Disease Control in IBD Patients Through Week 102

Celltrion, Inc. announced new data from a post-hoc analysis of the pivotal LIBERTY studies (LIBERTY-CD and LIBERTY-UC), showing that subcutaneous (SC) in...

February 17, 2026 | Tuesday | News
Formerra Expands Distribution of Evonik CARE Brand Medical Grades Across U.S. and Canada

Agreement Expands Access to Evonik's CARE Brand Medical Grades in the U.S. and Canada  Formerra, a leader in performance materials distribution, to...

February 05, 2026 | Thursday | News
Baoting Launches World’s First County-Level “Living Laboratory” to Advance 1.5°C Proactive Health Standards

Baoting Establishes World's First County-Level "Living Laboratory," Developing 1.5°C Proactive Health Standards  Breaking with decades of capit...

February 03, 2026 | Tuesday | News
Indian State of Telangana Unveils Global-Focused Life Sciences Policy at Davos

Positioning Telangana among the world's top five life sciences clusters by 2030 Targets USD 25 billion in investments Shifts focus from scale-led ma...

January 23, 2026 | Friday | News
Ouroboros Family Founders Fund to Lead $60 Million Series A Financing in Cytotheryx

Ouroboros Family Founders Fund I, LP announced this week it will lead a $60 million Series A financing in Cytotheryx, Inc., a preclinical cell therapy comp...

January 19, 2026 | Monday | News
Rakuten Medical Partners With LOTTE Biologics to Expand Manufacturing for Alluminox® Photoimmunotherapy

  Rakuten Medical, Inc. and LOTTE Biologics announced that they have signed a biopharmaceutical contract manufacturing agreement during the J.P....

January 15, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close